BMY
Bristol-Myers Squibb Company
NYSE: BMY · HEALTHCARE · DRUG MANUFACTURERS - GENERAL
$60.59
+5.21% today
Updated 2026-04-30
Market cap
$123.71B
P/E ratio
17.51
P/S ratio
2.57x
EPS (TTM)
$3.46
Dividend yield
4.32%
52W range
$41 – $62
Volume
12.1M
Bristol-Myers Squibb Company (BMY) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $2.08B | $3.15B | $3.71B | $4.07B | $4.49B | $4.84B | $6.94B | $3.54B | $3.15B | $2.10B | $3.06B | $5.28B | $7.07B | $8.07B | $14.05B | $16.21B | $13.07B | $13.86B | $15.19B | $14.16B |
| Capital expenditures | $793.00M | $843.00M | $941.00M | $730.00M | $424.00M | $367.00M | $548.00M | $537.00M | $526.00M | $820.00M | $1.22B | $1.05B | $951.00M | $836.00M | $753.00M | $973.00M | $1.12B | $1.21B | $1.25B | $1.31B |
| Depreciation | $927.00M | $892.00M | $816.00M | $707.00M | $607.00M | $628.00M | $681.00M | $763.00M | $467.00M | $376.00M | $382.00M | $789.00M | $637.00M | $1.75B | $10.38B | $10.69B | $10.28B | $9.76B | $9.60B | $4.01B |
| Stock-based comp | $112.00M | $133.00M | $181.00M | $183.00M | $193.00M | $161.00M | $154.00M | $191.00M | $213.00M | $235.00M | $205.00M | $199.00M | $221.00M | $441.00M | $779.00M | $583.00M | $457.00M | $518.00M | $507.00M | $553.00M |
| Free cash flow | $1.29B | $2.31B | $2.77B | $3.33B | $4.07B | $4.47B | $6.39B | $3.01B | $2.62B | $1.28B | $1.84B | $4.22B | $6.12B | $7.23B | $13.30B | $15.23B | $11.95B | $12.65B | $13.94B | $12.85B |
| Investing cash flow | $206.00M | $-202.00M | $5.08B | $-4.38B | $-3.81B | $-1.44B | $-6.73B | $-572.00M | $1.22B | $-1.57B | $1.48B | $-66.00M | $-2.00B | $-9.77B | $-10.86B | $-538.00M | $-1.06B | $-2.29B | $-21.35B | $-4.13B |
| Financing cash flow | $-3.35B | $-3.21B | $-2.58B | $-17.00M | $-3.34B | $-2.66B | $-4.33B | $-1.07B | $-2.44B | $-3.62B | $-2.65B | $-4.08B | $-3.54B | $7.62B | $-1.15B | $-16.22B | $-16.96B | $-9.42B | $5.13B | $-10.35B |
| Dividends paid | $2.20B | $2.21B | $2.46B | $2.48B | $2.20B | $2.25B | $2.29B | $2.31B | $2.40B | $2.48B | $2.55B | $2.58B | $2.61B | $2.68B | $4.08B | $4.40B | $4.63B | $4.74B | $4.86B | $5.04B |
| Share repurchases | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Net change in cash | — | — | — | $-293.00M | $-2.65B | $743.00M | $-4.12B | $1.93B | $1.99B | $-3.19B | $1.85B | $1.18B | $1.49B | $5.92B | $2.04B | $-555.00M | $-4.96B | — | — | — |